HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Takuya Nagano Selected Research

Takuya Nagano Research Topics

Disease

32Hepatocellular Carcinoma (Hepatoma)
10/2022 - 12/2013
6Neoplasms (Cancer)
01/2022 - 10/2010
4Liver Neoplasms (Liver Cancer)
08/2021 - 01/2019
4Chronic Hepatitis C
08/2019 - 12/2013
3Fatigue
06/2022 - 01/2022
3Liver Diseases (Liver Disease)
05/2021 - 03/2020
2Ascites
05/2022 - 04/2021
2Hypertension (High Blood Pressure)
03/2022 - 01/2022
2Neoplasm Metastasis (Metastasis)
01/2022 - 04/2021
2Infections
03/2020 - 08/2019
1Carcinoma (Carcinomatosis)
09/2022
1Hypothyroidism
06/2022
1Diarrhea
06/2022
1Edema (Dropsy)
05/2022
1Sarcopenia
07/2021
1Disease Progression
07/2021
1Hemorrhage
04/2021
1Alcoholic Fatty Liver
01/2021
1Non-alcoholic Fatty Liver Disease
01/2021
1Hand-Foot Syndrome
01/2017
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
08/2016
1Liver Abscess
08/2016
1Hemolytic-Uremic Syndrome
10/2010
1Thrombocytopenia (Thrombopenia)
10/2010
1Pancreatic Neoplasms (Pancreatic Cancer)
10/2010
1Hemolytic Anemia
10/2010
1Fibrosis (Cirrhosis)
07/2008

Drug/Important Bio-Agent (IBA)

19lenvatinibIBA
06/2022 - 01/2019
8atezolizumabIBA
10/2022 - 01/2022
8Bevacizumab (Avastin)FDA Link
10/2022 - 01/2022
7AlbuminsIBA
01/2022 - 01/2019
6BilirubinIBA
01/2022 - 01/2019
5Proteins (Proteins, Gene)FDA Link
05/2022 - 12/2013
4alpha-Fetoproteins (alpha-Fetoprotein)IBA
10/2022 - 04/2021
4InterferonsIBA
03/2020 - 12/2013
3C-Reactive ProteinIBA
10/2022 - 01/2022
3Antiviral Agents (Antivirals)IBA
05/2021 - 12/2013
3Tyrosine Kinase InhibitorsIBA
12/2020 - 01/2019
2Serum AlbuminIBA
01/2022 - 08/2021
2Sorafenib (BAY 43-9006)FDA Link
08/2021 - 01/2017
2Phospholipases (Phospholipase)IBA
01/2014 - 12/2013
1Urea (Carbamide)FDA LinkGeneric
05/2022
1Tumor Biomarkers (Tumor Markers)IBA
01/2022
1acarboxyprothrombin (PIVKA)IBA
01/2022
1regorafenibIBA
08/2021
1RamucirumabIBA
04/2021
1Immune Checkpoint InhibitorsIBA
01/2021
1Fetal Proteins (Fetoprotein)IBA
01/2021
1daclatasvirIBA
08/2019
18- cyclohexyl- N- ((dimethylamino)sulfonyl)- 1,1a,2,12b- tetrahydro- 11- methoxy- 1a- ((3- methyl- 3,8- diazabicyclo(3.2.1)oct- 8- yl)carbonyl)cycloprop(d)indolo(2,1- a)(2)benzazepine- 5- carboxamideIBA
08/2019
1asunaprevirIBA
08/2019
1Biological ProductsIBA
08/2016
1IronIBA
03/2016
1LDL Lipoproteins (beta Lipoproteins)IBA
01/2014
1LDL Receptors (LDL Receptor)IBA
01/2014
1GemcitabineFDA Link
10/2010
1Immunoglobulin A (IgA)IBA
07/2008
1Alanine Transaminase (SGPT)IBA
07/2008
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
07/2008

Therapy/Procedure

14Therapeutics
06/2022 - 12/2013
1Immunotherapy
10/2022
1Radiotherapy
05/2019
1Splenectomy
10/2010
1Adjuvant Chemotherapy
10/2010
1Pancreatectomy
10/2010
1Drug Therapy (Chemotherapy)
10/2010